Disease
3 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 9, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
This is an active Phase 2 trial registration with no reported results; it describes a planned study of a combination approach in triple-negative breast cancer with a metabolic biomarker as primary outcome.
AUG 20, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
Phase 2 trial with estimated enrollment of 36 participants testing a four-drug combination; no results are reported in this registry record.
AUG 18, 2026 · PHASE 2/3 TRIAL
ClinicalTrials.gov
This is a clinical trial registry record describing a planned Phase 2/3 interventional study with no results posted; the study is actively recruiting and outcome data have not yet been reported.